PRVA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PRVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Privia Health Group's yield on cost for the quarter that ended in Sep. 2024 was 0.00.
The historical rank and industry rank for Privia Health Group's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Health Information Services subindustry, Privia Health Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Privia Health Group's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Privia Health Group is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Privia Health Group (NAS:PRVA) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Privia Health Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Parth Mehrotra | officer: President and COO | 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203 |
Adam Boehler | director | 1215 5TH AVE N,, NASHVILLE TN 37208 |
Thomas A Mccarthy | director | 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL18Y, PHILADELPHIA PA 19192 |
Thomas Bartrum | officer: EVP, General Counsel | 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203 |
David Mountcastle | officer: Chief Financial Officer | 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203 |
Matthew Shawn Morris | director, officer: Chief Executive Officer | 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203 |
William M Sullivan | director | ONE PENN PLAZA, SUITE 5300, NY NY 10119 |
Pamela O Kimmet | director | 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418 |
David S Wichmann | director | BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752 |
Goldman Sachs Group Inc | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Jeffrey Daniel Bernstein | director | 200 WEST STREET, NEW YORK NY 10282 |
Pamplona Capital Partners Iii, L.p. | 10 percent owner | 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108 |
Mbd Advisors, L.l.c. | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Jeffrey B Butler | director | 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101 |
David P King | director | PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203 |
From GuruFocus
By GuruFocus News • 11-07-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 05-23-2024
By GuruFocus Research • 02-27-2024
By GuruFocus News • 11-06-2024
By Marketwired • 08-08-2024
By GuruFocus Research • 02-08-2024
By GlobeNewswire • 10-29-2024
By Marketwired • 05-30-2024
By GuruFocus Research • 05-10-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.